Drugs
FTC Charges Mylan with Restraint of Trade, Monopolization, and Conspiracy
Mylan Laboratories, the nation's second-largest generic drug manufacturer, has been charged by the Federal Trade Commission with restraint of trade, monopolization, and conspiracy to monopolize the markets for two widely prescribed anti-anxiety drugs, lorazepam and clorazepate. The FTC alleges that Mylan's illegal conduct resulted in price